Babraham Institute

I am a Senior Staff Scientist in Signalling Proteomics at the Babraham Institute supporting a range of proteomics applications across the department. A key focus is working on proteomics method development for studying protein ubiquitylation, misfolding, and aggregation in aging. Most recently, this has included devising a pipeline for the LC-MS characterisation of polyubiquitylated proteins and a simplified proteomics clean-up approach (SP4). I did a PhD and postdoc in cancer proteomics at Southampton University and a postdoc in biomarker discovery at UCL. I am also a serial discussion group founder (see also LPDG).

ThermoFisher Scientific

I have a degree in Chemistry from the University of York and a PhD in analytical chemistry from the University of Reading. Following a post-doc in mass spectrometry in the Chemistry department at Oxford, and working as an application scientist at Waters, I worked in and ran Proteomics Core Facilities in the UK and Germany, including the EMBL in Heidelberg, the Leibniz Institute on Aging in Jena, The Francis Crick Institute in London and CRUK Cambridge. After many years as an experienced Thermo customer, I joined the company in 2023 as a Technical Sales Specialist, supporting the whole of the UK/Ireland, Benelux and Nordic regions, in all things proteomics. When I’m not talking about proteomics and mass spectrometry I enjoy ceroc dancing, tennis, scuba diving, travelling, and spending time with my cats, who like to join in on Teams meetings whenever I work from home.

Cambridge University  

I began my career at the Horse Racing Forensic laboratory in Newmarket in 2000, developing methods to detect steroid abuse in horses and pro-steroid contaminants in sports supplements. I then performed a part time PhD with Colin Creaser at the University of Loughborough (2005-2010) developing plasma proteomics methods to detect growth hormone abuse in athletes and then transferred to the Bioanalytical Group to develop GLP and GCP validated methods for measuring peptide and protein drugs for pharmaceutical companies. In 2016 I moved to the University of Cambridge to set up a Peptidomics facility and has since developed methods to measure endogenous peptides and proteins in plasma, tissue homogenates, primary culture supernatants, organoids and sorted cells to support research performed by the MRC Institute of Metabolic Science.

Bicycle Therapeutics

I am a Principal Scientist specialising in protein mass spectrometry at Bicycle Therapeutics. Before that I was a mass spectrometrist in the High Throughput Screening team at AstraZeneca and before that the Biophysics group at Astex and the Analytical Development team at Cantab Pharmaceuticals. My primary role is to ensure that all the reagents provided to the downstream discovery efforts at Bicycle are of the highest quality, and my secondary role is to ensure the company is best positioned to leverage the maximum benefit from mass spectrometry. Mass spec, in all its various guises can answer a lot of questions at all stages of pharmaceutical discovery and development, and in many other industries. I hope CamsPaMS will spread the word and enable more scientists to use this amazing technology.

EMBL-EBI

  I am currently a senior scientific database curator and project liaison at UniProt, based at EMBL-EBI in Hinxton, Cambridge. I am passionate about scientific communication and work with both the curation and website development teams at UniProt to drive user-centric improvements and data integration in response to community feedback. My research background is in wet-lab proteomics investigation of aberrant signalling pathways in cancer and I now act as UniProt’s proteomics subject matter expert and focus my efforts on integration of large-scale PTM-enriched proteomics data and curation of mammalian proteins involved in cell adhesion, disease mechanisms and osteogenesis.